Jyoti Patel, MD, and Jessica Donington, MD, in a thoracic oncology tumor board meeting
University of Chicago Medicine's lung cancer team meets regularly to develop the best treatment plan for each patient. Seated at the table are medical oncologist Jyoti D. Patel, MD, left, and thoracic surgeon Jessica S. Donington, MD, MSCR, chief of the Section of Thoracic Surgery.

Immunotherapy harnesses the power of the immune system to treat cancer. There are several types of immunotherapy, which work in different ways to treat different types of cancer.

Immune checkpoint inhibitors are used to treat certain non-small cell lung cancers. These drugs block proteins (PD-1 and PD-L1) that cancer cells use to disarm an immune response, enabling disease-fighting T-cells to attack, shrink or destroy tumor cells.

In some cases, checkpoint inhibitors (e.g. pembrolizumab, nivolumab, atezolizumab, durvalumab) are given before, along with, or instead of chemotherapy.

Q & A with UChicago Medicine Lung Cancer Experts

UChicago Medicine physicians Jyoti Patel, MD, and D. Kyle Hogarth, MD, answer questions about lung cancer and discuss the latest advances in lung cancer prevention, screening, diagnosis and treatment.

Watch Video

Request an Appointment

* Required Field